Pro-inflammatory cytokines in stress-induced depression: Novel insights into mechanisms and promising therapeutic strategies

Prog Neuropsychopharmacol Biol Psychiatry. 2024 Apr 20:131:110931. doi: 10.1016/j.pnpbp.2023.110931. Epub 2024 Jan 2.

Abstract

Stress-mediated depression is one of the common psychiatric disorders with a high prevalence and suicide rate, there is a lack of effective treatment. Accordingly, effective treatments with few adverse effects are urgently needed. Pro-inflammatory cytokines (PICs) may play a key role in stress-mediated depression. Thereupon, both preclinical and clinical studies have found higher levels of IL-1β, TNF-α and IL-6 in peripheral blood and brain tissue of patients with depression. Recent studies have found PICs cause depression by affecting neuroinflammation, monoamine neurotransmitters, hypothalamic pituitary adrenal axis and neuroplasticity. Moreover, they play an important role in the symptom, development and progression of depression, maybe a potential diagnostic and therapeutic marker of depression. In addition, well-established antidepressant therapies have some relief on high levels of PICs. Importantly, anti-inflammatory drugs relieve depressive symptoms by reducing levels of PICs. Collectively, reducing PICs may represent a promising therapeutic strategy for depression.

Keywords: Depression; Hypothalamic pituitary adrenal; Neuroinflammation; Neurotransmitter; Pro-inflammatory cytokine.

Publication types

  • Review

MeSH terms

  • Cytokines* / metabolism
  • Depression / drug therapy
  • Depression / etiology
  • Humans
  • Hypothalamo-Hypophyseal System / metabolism
  • Mental Disorders*
  • Pituitary-Adrenal System / metabolism

Substances

  • Cytokines